[1]
|
中华医学会糖尿病学分会神经并发症学组. 糖尿病神经病变诊治专家共识(2021年版) [J]. 中华糖尿病杂志, 2021, 13(6): 540-557.
|
[2]
|
Hicks, C.W. and Selvin, E. (2019) Epidemiology of Peripheral Neuropathy and Lower Ex-tremity Disease in Diabetes. Current Diabetes Reports, 19, 86. https://doi.org/10.1007/s11892-019-1212-8
|
[3]
|
Feldman, E.L., Nave, K.A., Jensen, T.S., et al. (2017) New Hori-zons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron, 93, 1296-1313. https://doi.org/10.1016/j.neuron.2017.02.005
|
[4]
|
Sadosky, A., Schaefer, C., Mann, R., et al. (2013) Burden of Illness Associated with Painful Diabetic Peripheral Neuropathy among Adults Seeking Treatment in the US: Results from a Retrospective Chart Review and Cross-Sectional Survey. Diabetes, Metabolic Syndrome and Obesity, 6, 79-92. https://doi.org/10.2147/DMSO.S37415
|
[5]
|
Aghamiri, S.H., Komlakh, K. and Ghaffari, M. (2022) The Crosstalk among TLR2, TLR4 and Pathogenic Pathways; a Treasure Trove for Treatment of Diabetic Neuropathy. Inflammophar-macology, 30, 51-60.
https://doi.org/10.1007/s10787-021-00919-3
|
[6]
|
Mu, Z.P., Wang, Y.G., Li, C.Q., et al. (2017) Association be-tween Tumor Necrosis Factor-α and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: A Meta-Analysis. Molecular Neurobiology, 52, 983-996.
https://doi.org/10.1007/s12035-016-9702-z
|
[7]
|
Elzinga, S., Murdock, B.J., Guo, K., et al. (2019) Toll-Like Re-ceptors and Inflammation in Metabolic Neuropathy; a Role in Early versus Late Disease? Experimental Neurology, 320, Article ID: 112967.
https://doi.org/10.1016/j.expneurol.2019.112967
|
[8]
|
Zhu, T., Meng, Q., Ji, J., et al. (2015) Toll-Like Receptor 4 and Tumor Necrosis Factor-Alpha as Diagnostic Biomarkers for Diabetic Peripheral Neuropathy. Neuroscience Letters, 585, 28-32. https://doi.org/10.1016/j.neulet.2014.11.020
|
[9]
|
Rudofsky, G., Reismann, P., Witte, S., et al. (2004) Asp299Gly and Thr399Ile Genotypes of the TLR4 Gene Are Associated with a Reduced Prevalence of Diabetic Neurop-athy in Patients with Type 2 Diabetes. Diabetes Care, 27, 179-183. https://doi.org/10.2337/diacare.27.1.179
|
[10]
|
Lehmann, S.M., Krüger, C., Park, B., et al. (2012) An Unconven-tional Role for miRNA: Let-7 Activates Toll-Like Receptor 7 and Causes Neurodegeneration. Nature Neuroscience, 15, 827-835. https://doi.org/10.1038/nn.3113
|
[11]
|
Bali, K.K. and Kuner, R. (2014) Noncoding RNAs: Key Molecules in Understanding and Treating Pain. Trends in Molecular Medicine, 20, 437-448. https://doi.org/10.1016/j.molmed.2014.05.006
|
[12]
|
Yang, K., He, Y.S., Wang, X.Q., et al. (2011) MiR-146a In-hibits Oxidized Low-Density Lipoprotein-Induced Lipid Accumulation and Inflammatory Response via Targeting Toll-Like Receptor 4. FEBS Letters, 585, 854-860.
https://doi.org/10.1016/j.febslet.2011.02.009
|
[13]
|
Feng, Y., Chen, L., Luo, Q., et al. (2018) Involvement of mi-croRNA-146a in Diabetic Peripheral Neuropathy through the Regulation of Inflammation. Drug Design, Development and Therapy, 12, 171-177.
https://doi.org/10.2147/DDDT.S157109
|
[14]
|
王征, 李艳芳. microRNA-146a在2型糖尿病周围神经病变患者血清中的表达及其临床意义[J]. 中国慢性病预防与控制, 2019, 27(1): 28-31.
|
[15]
|
Fukunaga, M., Miyata, S., Higo, S., et al. (2005) Methylglyoxal Induces Apoptosis through Oxidative Stress-Mediated Activation of p38 Mito-gen-Activated Protein Kinase in Rat Schwann Cells. Annals of the New York Academy of Sciences, 1043, 151-157. https://doi.org/10.1196/annals.1333.019
|
[16]
|
Sugimoto, K., Nishizawa, Y., Horiuchi, S., et al. (1997) Localization in Human Diabetic Peripheral Nerve of N(epsilon)-carboxymethyllysine-Protein Adducts, an Advanced Glycation End-product. Diabetologia, 40, 1380-1387.
https://doi.org/10.1007/s001250050839
|
[17]
|
Bierhaus, A., Haslbeck, K.M., Humpert, P.M., et al. (2004) Loss of Pain Perception in Diabetes Is Dependent on a Receptor of the Immunoglobulin Superfamily. The Journal of Clinical In-vestigation, 114, 1741-1751.
https://doi.org/10.1172/JCI18058
|
[18]
|
Thornalley, P.J. (2002) Glycation in Diabetic Neuropathy: Characteristics, Consequences, Causes, and Therapeutic Options. International Review of Neurobiology, 50, 37-57. https://doi.org/10.1016/S0074-7742(02)50072-6
|
[19]
|
Skapare, E., Konrade, I., Liepinsh, E., et al. (2013) Associa-tion of Reduced Glyoxalase 1 Activity and Painful Peripheral Diabetic Neuropathy in Type 1 and 2 Diabetes Mellitus Pa-tients. Journal of Diabetes and Its Complications, 27, 262-267. https://doi.org/10.1016/j.jdiacomp.2012.12.002
|
[20]
|
Groener, J.B., Reismann, P., Fleming, T., et al. (2013) C332C Genotype of Glyoxalase 1 and Its Association with Late Diabetic Complications.Experimental and Clinical Endocrinolo-gy & Diabetes, 121, 436-439.
https://doi.org/10.1055/s-0033-1345124
|
[21]
|
Negi, G., Kumar, A., Joshi, R.P., et al. (2011) Oxidative Stress and Nrf2 in the Pathophysiology of Diabetic Neuropathy: Old Perspective with a New Angle. Biochemical and Biophysical Research Communications, 408, 1-5.
https://doi.org/10.1016/j.bbrc.2011.03.087
|
[22]
|
Xu, C., Hou, B., He, P., et al. (2020) Neuroprotective Effect of Salvianolic Acid A against Diabetic Peripheral Neuropathy through Modulation of Nrf2. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 6431459.
https://doi.org/10.1155/2020/6431459
|
[23]
|
Odagiri, E. (2005) Neuron Specific Enolase. Nihon Rinsho, 63, 717-719.
|
[24]
|
Li, J., Zhang, H., Xie, M., et al. (2013) NSE, a Potential Biomarker, Is Closely Connected to Diabetic Pe-ripheral Neuropathy. Diabetes Care, 36, 3405-3410. https://doi.org/10.2337/dc13-0590
|
[25]
|
Ummer, V.S., Maiya, A.G., et al. (2020) Effect of Photobiomodulation on Serum Neuron Specific Enolase (NSE) among Patients with Diabetic Peripheral Neuropathy—A Pilot Study. Diabetology & Metabolic Syndrome, 14, 1061-1063.
https://doi.org/10.1016/j.dsx.2020.06.065
|
[26]
|
Morgenstern, J., Groener, J.B., Jende, J.M.E., et al. (2021) Neu-ron-Specific Biomarkers Predict Hypo- and Hyperalgesia in Individuals with Diabetic Peripheral Neuropathy. Diabetolo-gia, 64, 2843-2855.
https://doi.org/10.1007/s00125-021-05557-6
|
[27]
|
Park, H.T., Kim, Y.H., Lee, K.E., et al. (2020) Behind the Pa-thology of Macrophage-Associated Demyelination in Inflammatory Neuropathies: Demyelinating Schwann Cells. Cellu-lar and Molecular Life Sciences, 77, 2497-2506.
https://doi.org/10.1007/s00018-019-03431-8
|
[28]
|
Jende, J.M.E., Groener, J.B., Kender, Z., et al. (2020) Structural Nerve Remodeling at 3-T MR Neurography Differs between Painful and Painless Diabetic Polyneuropathy in Type 1 or 2 Diabetes. Radiology, 294, 405-414.
https://doi.org/10.1148/radiol.2019191347
|
[29]
|
Groener, J.B., Jende, J.M.E., Kurz, F.T., et al. (2020) Understand-ing Diabetic Neuropathy—From Subclinical Nerve Lesions to Severe Nerve Fiber Deficits: A Cross-Sectional Study in Patients with Type 2 Diabetes and Healthy Control Subjects. Diabetes, 69, 436-447. https://doi.org/10.2337/db19-0197
|
[30]
|
Sandelius, Å., Zetterberg, H., Blennow, K., et al. (2018) Plasma Neurofil-ament Light Chain Concentration in the Inherited Peripheral Neuropathies. Neurology, 90, e518-e524. https://doi.org/10.1212/WNL.0000000000004932
|
[31]
|
Evans, L.J., Loescher, A.R., Boissonade, F.M., et al. (2014) Temporal Mismatch between Pain Behaviour, Skin Nerve Growth Factor and Intra-Epidermal Nerve Fibre Density in Trigeminal Neuropathic Pain. BMC Neuroscience, 15, 1.
https://doi.org/10.1186/1471-2202-15-1
|
[32]
|
Kim, H.C., Cho, Y.J., Ahn, C.W., et al. (2009) Nerve Growth Factor and Expression of Its Receptors in Patients with Diabetic Neuropathy. Diabetic Medicine, 26, 1228-1234. https://doi.org/10.1111/j.1464-5491.2009.02856.x
|
[33]
|
Sun, Q., Tang, D.D., Yin, E.G., et al. (2018) Diagnostic Significance of Serum Levels of Nerve Growth Factor and Brain Derived Neurotrophic Factor in Diabetic Peripheral Neuropathy. Medical Science Monitor, 24, 5943-5950.
https://doi.org/10.12659/MSM.909449
|
[34]
|
Faradji, V. and Sotelo, J. (1990) Low Serum Levels of Nerve Growth Factor in Diabetic Neuropathy. Acta Neurologica Scandinavica, 81, 402-406. https://doi.org/10.1111/j.1600-0404.1990.tb00984.x
|
[35]
|
Kamiya, H., Zhangm, W. and Sima, A.A. (2005) Apop-totic Stress Is Counterbalanced by Survival Elements Preventing Programmed Cell Death of Dorsal Root Ganglions in Subacute Type 1 Diabetic BB/Wor Rats. Diabetes, 54, 3288-3295.
https://doi.org/10.2337/diabetes.54.11.3288
|
[36]
|
Benn, S.C., Perrelet, D., Kato, A.C., et al. (2002) Hsp27 Upregu-lation and Phosphorylation Is Required for Injured Sensory and Motor Neuron Survival. Neuron, 36, 45-56. https://doi.org/10.1016/S0896-6273(02)00941-8
|